1. Home
  2. SGHT vs LFMD Comparison

SGHT vs LFMD Comparison

Compare SGHT & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.83

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.94

Market Cap

190.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
LFMD
Founded
2011
1994
Country
United States
United States
Employees
N/A
384
Industry
Medical Specialities
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
190.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SGHT
LFMD
Price
$3.83
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$9.08
$9.14
AVG Volume (30 Days)
230.7K
930.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
N/A
Revenue This Year
$11.67
$17.52
Revenue Next Year
$10.39
$18.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.51
$2.60
52 Week High
$9.24
$15.34

Technical Indicators

Market Signals
Indicator
SGHT
LFMD
Relative Strength Index (RSI) 46.77 58.80
Support Level $3.30 $3.39
Resistance Level $4.29 $4.19
Average True Range (ATR) 0.20 0.29
MACD 0.09 0.01
Stochastic Oscillator 65.26 67.71

Price Performance

Historical Comparison
SGHT
LFMD

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

Share on Social Networks: